CIAM
IONS icon

Caitong International Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Caitong International Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$526 Buy
+7
New +$552 ﹤0.01% 1632
2025
Q2 		– Sell
-28
Closed -$845 – 2226
2025
Q1 		$845 Buy
28
+25
+833% +$819 ﹤0.01% 1622
2024
Q4 		$105 Buy
+3
New +$112 ﹤0.01% 1615

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caitong International Asset Management's IONS Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 7 shares worth $526. The stake represents ﹤0.01% of the portfolio and ranks #1632 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in IONS as recently as Q1 2025.

Caitong International Asset Management first reported a position in IONS in Q4 2024 and has held it in 3 quarters since. The position peaked at $845 in Q1 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Caitong International Asset Management held 7 shares of Ionis Pharmaceuticals worth $526 as of Q1 2026.
  • Ionis Pharmaceuticals was a new Caitong International Asset Management position in Q1 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1632 holding.
  • Caitong International Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • Caitong International Asset Management's Ionis Pharmaceuticals position peaked at $845 in Q1 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.